<DOC>
	<DOCNO>NCT01129388</DOCNO>
	<brief_summary>Primary objective : - Assess effect clopidogrel ( 300 mg load dose follow 4 day 75 mg/day ) Adenosine diphosphate ( ADP ) -induced platelet aggregation give either alone morning , association omeprazole 80 mg/day even 12-hours interval healthy male female subject Secondary Objectives : - Compare pharmacokinetic profile clopidogrel active metabolite clopidogrel give either alone alone morning , association omeprazole even 12-hours interval</brief_summary>
	<brief_title>Interaction Study Clopidogrel 300/75 mg Given Alone With Omeprazole 80 mg 12 Hours Apart Healthy Subjects</brief_title>
	<detailed_description>The total study duration per subject 8-9 week break follow : - Screening : 2 21 day first dose - Period clopidogrel/placebo : 7 day include 5 day treatment - Period clopidogrel/placebo + omeprazole : 12 day include 10 day treatment - Washout period : least 14 day period last dosing respect clopidogrel treatment - End study : 7 10 day last dosing</detailed_description>
	<mesh_term>Clopidogrel</mesh_term>
	<mesh_term>Ticlopidine</mesh_term>
	<mesh_term>Omeprazole</mesh_term>
	<criteria>Healthy subject , determine medical history , physical examination include vital sign clinical laboratory test . body weight 50 kg 95 kg male , 40 kg 85 kg female , Body Mass Index ( BMI ) 18 30 kg/mÂ² Evidence inherit disorder coagulation/hemostasis function Smoking 5 cigarette equivalent per day Abnormal hemostasis screen Unability abstain intake drug affect hemostasis throughout whole study duration Any contraindication clopidogrel and/or omeprazole The information intend contain consideration relevant patient 's potential participation clinical trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2011</verification_date>
</DOC>